Yipinhong Pharmaceutical Co Ltd
SZSE:300723

Watchlist Manager
Yipinhong Pharmaceutical Co Ltd Logo
Yipinhong Pharmaceutical Co Ltd
SZSE:300723
Watchlist
Price: 16.83 CNY -4.54%
Market Cap: 7.5B CNY
Have any thoughts about
Yipinhong Pharmaceutical Co Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

51
Current
35.7
Median
13.7
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
51
=
Enterprise Value
8.6B CNY
/
EBITDA
168.5m CNY
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
19.9
2-Years Forward
EV/EBITDA
16.4
3-Years Forward
EV/EBITDA
14.5

See Also

Discover More